Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheila A Doggrell

Showing results (81-90 of 220) with videos related to

Pageof 22
Sort By:
Expert Opinion on Pharmacotherapy|April 6, 2002
Fondaparinux versus enoxaparin for the prevention of venous thromboembolismSheila A Doggrell
Expert Opinion on Investigational Drugs|July 19, 2005
The nitrosterols--a step forward from the steroid anti-inflammatory drugs?Sheila A Doggrell
Expert Opinion on Investigational Drugs|July 19, 2005
New drugs being developed for the treatment of tuberculosisSheila A Doggrell
Expert Opinion on Therapeutic Targets|August 9, 2005
Neuromedin U--a new target in obesitySheila A Doggrell
Current Opinion in Investigational Drugs (London, England : 2000)|September 29, 2005
Clinical potential of nitric oxide-independent soluble guanylate cyclase activatorsSheila A Doggrell
Current Opinion in Investigational Drugs (London, England : 2000)|April 22, 2006
New targets in and potential treatments for cholesterol gallstone diseaseSheila A Doggrell
Expert Opinion on Pharmacotherapy|April 23, 2010
Oral fingolimod for relapsing-remitting multiple sclerosis Evaluation of: Kappos L, Radue E-M, O'Connor P, et al. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 2010;362:387-401; and Cohen JA, Barkhof F, Comi G, et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 2010;362:402-15Sheila A Doggrell
Expert Opinion on Pharmacotherapy|April 21, 2026
Is supplemental vitamin D useful in the clinically isolated syndrome (CIS) typical of multiple sclerosis?Sheila A Doggrell
Expert Review of Clinical Pharmacology|November 26, 2011
Found in translation: integrated approaches to drug developmentSheila A Doggrell
Expert Opinion on Pharmacotherapy|June 4, 2008
Is long-term adjuvant treatment of breast cancer with anastrozole indicated?Sheila A Doggrell
Pageof 22

Showing results (81-90 of 220) with videos related to

Sort By:
Pageof 22
Expert Opinion on Pharmacotherapy|April 6, 2002
Fondaparinux versus enoxaparin for the prevention of venous thromboembolismSheila A Doggrell
Expert Opinion on Investigational Drugs|July 19, 2005
The nitrosterols--a step forward from the steroid anti-inflammatory drugs?Sheila A Doggrell
Expert Opinion on Investigational Drugs|July 19, 2005
New drugs being developed for the treatment of tuberculosisSheila A Doggrell
Expert Opinion on Therapeutic Targets|August 9, 2005
Neuromedin U--a new target in obesitySheila A Doggrell
Current Opinion in Investigational Drugs (London, England : 2000)|September 29, 2005
Clinical potential of nitric oxide-independent soluble guanylate cyclase activatorsSheila A Doggrell
Current Opinion in Investigational Drugs (London, England : 2000)|April 22, 2006
New targets in and potential treatments for cholesterol gallstone diseaseSheila A Doggrell
Expert Opinion on Pharmacotherapy|April 23, 2010
Oral fingolimod for relapsing-remitting multiple sclerosis Evaluation of: Kappos L, Radue E-M, O'Connor P, et al. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 2010;362:387-401; and Cohen JA, Barkhof F, Comi G, et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 2010;362:402-15Sheila A Doggrell
Expert Opinion on Pharmacotherapy|April 21, 2026
Is supplemental vitamin D useful in the clinically isolated syndrome (CIS) typical of multiple sclerosis?Sheila A Doggrell
Expert Review of Clinical Pharmacology|November 26, 2011
Found in translation: integrated approaches to drug developmentSheila A Doggrell
Expert Opinion on Pharmacotherapy|June 4, 2008
Is long-term adjuvant treatment of breast cancer with anastrozole indicated?Sheila A Doggrell
Pageof 22